Pilot series of robot-assisted laparoscopic subtotal gastrectomy with extended lymphadenectomy for gastric cancer
- 230 Downloads
Robotic surgery is evolving as a therapeutic tool for thoracic and urologic applications; however, its use in gastric cancer surgery has not been extensively reported. The objective of this pilot series was to assess the feasibility of using robotic surgery in performing an extended lymphadenectomy for gastric cancer.
Between June 2005 and July 2006, seven patients (3 female, 4 male) underwent combined laparoscopic subtotal gastrectomy with omentectomy and robot-assisted extended lymphadenectomy using the da Vinci® Surgical System for early distal gastric tumors. The mean age of the patients was 64 years. Tumor staging ranged from 0 to II. Six patients had adenocarcinoma and one patient had a high-grade dysplastic adenoma.
All procedures were completed successfully without conversion. The median operating time was 420 min. There was one intraoperative complication requiring a colon resection for a devascularized segment. The median number of nodes harvested was 24 (range = 17–30). Resection margins were negative in all specimens. Patients were hospitalized a median of 4 days (range = 3–9). Thirty-day mortality was 0%. Patients resumed a solid diet a median of 4 days postoperatively. Median followup was 9 (range = 0–10) months. There have been no tumor recurrences to date.
Extended lymphadenectomy for gastric cancer using robotic surgery is safe and allows for an adequate lymph node retrieval. Our preliminary results suggest that this novel technique offers short hospital stays and low morbidity for patients undergoing surgical resection of distal gastric malignancies. Future studies will be necessary to better define the role of robotic surgery in gastric cancer treatment.
KeywordsGastric cancer Lymphadenectomy Robotics Minimally invasive surgery Robot-assisted gastrectomy
- 3.Bonenkamp J, Hermans J, Sasako, Van De Velde C, for the Dutch Gastric Cancer Group (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908–914Google Scholar
- 5.Cushieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook R, for the Surgical Cooperative Group (1996) Post-operative morbidity and mortality after D1 and D2 resections for gastric cancer; preliminary results of the MRC randomized controlled surgical trial. Lancet 347: 995–999CrossRefGoogle Scholar
- 6.Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayer P, for the Surgical Cooperative Group (1999) Patient survival after D1, and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79: 1522–1530PubMedCrossRefGoogle Scholar
- 10.Hartgrink H, Van de Velde C, Putter H, Bonenkamp J, Kranebarg E, Songun I, Welvaart K, van Krieken J, Plukker J, van Elk P, Obertop H, Gouma D, van Lanschot J, Taat C, deGraaf P, von Meyenfeldt M, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized dutch gastric cancer group trial. J Clin Oncol 22: 2069–2077PubMedCrossRefGoogle Scholar
- 16.Kim M, Kim K, Kim Hyung, Jung G (2005) Comparison of laparoscopy-assisted by conventional open distal gastrectomy and extraperigastric lymph node dissection in early gastric cancer. J Surg Oncol 91: 90–94Google Scholar
- 27.Uyama I, Sugioika A, Fujita J,Komori Y, Matsui H, Soga R, Wakayama A, Okamota K, Ohyama A, Hasumi A (1999). Completely laparoscopic extraperigastric lymph node dissection for gastric malignancies located in the middle or lower third of the stomach. Gastric Cancer 2: 186–190PubMedCrossRefGoogle Scholar